Literature DB >> 23007843

Extensive characterization of sphere models established from colorectal cancer cell lines.

Ada Collura1, Laetitia Marisa, Diletta Trojan, Olivier Buhard, Anaïs Lagrange, Arnaud Saget, Marianne Bombled, Patricia Méchighel, Mira Ayadi, Martine Muleris, Aurélien de Reynies, Magali Svrcek, Jean-François Fléjou, Jean-Claude Florent, Florence Mahuteau-Betzer, Anne-Marie Faussat, Alex Duval.   

Abstract

Links between cancer and stem cells have been proposed for many years. As the cancer stem cell (CSC) theory became widely studied, new methods were developed to culture and expand cancer cells with conserved determinants of "stemness". These cells show increased ability to grow in suspension as spheres in serum-free medium supplemented with growth factors and chemicals. The physiological relevance of this phenomenon in established cancer cell lines remains unclear. Cell lines have traditionally been used to explore tumor biology and serve as preclinical models for the screening of potential therapeutic agents. Here, we grew cell-forming spheres (CFS) from 25 established colorectal cancer cell lines. The molecular and cellular characteristics of CFS were compared to the bulk of tumor cells. CFS could be isolated from 72 % of the cell lines. Both CFS and their parental CRC cell lines were highly tumorigenic. Compared to their parental cells, they showed similar expression of putative CSC markers. The ability of CRC cells to grow as CFS was greatly enhanced by prior treatment with 5-fluorouracil. At the molecular level, CFS and parental CRC cells showed identical gene mutations and very similar genomic profiles, although microarray analysis revealed changes in CFS gene expression that were independent of DNA copy-number. We identified a CFS gene expression signature common to CFS from all CRC cell lines, which was predictive of disease relapse in CRC patients. In conclusion, CFS models derived from CRC cell lines possess interesting phenotypic features that may have clinical relevance for drug resistance and disease relapse.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23007843     DOI: 10.1007/s00018-012-1160-9

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  43 in total

Review 1.  Microenvironmental regulation of stem cells in intestinal homeostasis and cancer.

Authors:  Jan Paul Medema; Louis Vermeulen
Journal:  Nature       Date:  2011-06-15       Impact factor: 49.962

Review 2.  The chromosomal instability pathway in colon cancer.

Authors:  Maria S Pino; Daniel C Chung
Journal:  Gastroenterology       Date:  2010-06       Impact factor: 22.682

Review 3.  Mutations at coding repeat sequences in mismatch repair-deficient human cancers: toward a new concept of target genes for instability.

Authors:  Alex Duval; Richard Hamelin
Journal:  Cancer Res       Date:  2002-05-01       Impact factor: 12.701

Review 4.  Tumour stem cells and drug resistance.

Authors:  Michael Dean; Tito Fojo; Susan Bates
Journal:  Nat Rev Cancer       Date:  2005-04       Impact factor: 60.716

5.  Extensive characterization of genetic alterations in a series of human colorectal cancer cell lines.

Authors:  J Gayet; X P Zhou; A Duval; S Rolland; J M Hoang; P Cottu; R Hamelin
Journal:  Oncogene       Date:  2001-08-16       Impact factor: 9.867

Review 6.  Mechanisms of cancer drug resistance.

Authors:  Michael M Gottesman
Journal:  Annu Rev Med       Date:  2002       Impact factor: 13.739

7.  Cell culture of human colon adenomas and carcinomas.

Authors:  J K Willson; G N Bittner; T D Oberley; L F Meisner; J L Weese
Journal:  Cancer Res       Date:  1987-05-15       Impact factor: 12.701

Review 8.  Stem cell-like cancer cells in cancer cell lines.

Authors:  Toru Kondo
Journal:  Cancer Biomark       Date:  2007       Impact factor: 4.388

9.  Colon cancer stem cells dictate tumor growth and resist cell death by production of interleukin-4.

Authors:  Matilde Todaro; Mileidys Perez Alea; Anna B Di Stefano; Patrizia Cammareri; Louis Vermeulen; Flora Iovino; Claudio Tripodo; Antonio Russo; Gaspare Gulotta; Jan Paul Medema; Giorgio Stassi
Journal:  Cell Stem Cell       Date:  2007-10-11       Impact factor: 24.633

10.  Response of small-cell lung cancer xenografts to chemotherapy: multidrug resistance and direct clinical correlates.

Authors:  M F Poupon; F Arvelo; A F Goguel; Y Bourgeois; M Jacrot; N Hanania; R Arriagada; T Le Chevalier
Journal:  J Natl Cancer Inst       Date:  1993-12-15       Impact factor: 13.506

View more
  12 in total

1.  Chronic chemotherapeutic stress promotes evolution of stemness and WNT/beta-catenin signaling in colorectal cancer cells: implications for clinical use of WNT-signaling inhibitors.

Authors:  Meriam Ayadi; Anaïs Bouygues; Djamila Ouaret; Nathalie Ferrand; Salem Chouaib; Jean-Paul Thiery; Christian Muchardt; Michèle Sabbah; Annette K Larsen
Journal:  Oncotarget       Date:  2015-07-30

2.  GOLPH2-regulated oncolytic adenovirus, GD55, exerts strong killing effect on human prostate cancer stem-like cells in vitro and in vivo.

Authors:  Chang Ying; Bo-Duan Xiao; Yun Qin; Bin-Rong Wang; Xin-Yuan Liu; Ru-Wei Wang; Ling Fang; Hui Yan; Xiu-Mei Zhou; Yi-Gang Wang
Journal:  Acta Pharmacol Sin       Date:  2017-09-07       Impact factor: 6.150

Review 3.  Tumor-Initiating Cells: a criTICal review of isolation approaches and new challenges in targeting strategies.

Authors:  Komal Qureshi-Baig; Pit Ullmann; Serge Haan; Elisabeth Letellier
Journal:  Mol Cancer       Date:  2017-02-16       Impact factor: 27.401

4.  TGF-β1 exposure induces epithelial to mesenchymal transition both in CSCs and non-CSCs of the A549 cell line, leading to an increase of migration ability in the CD133+ A549 cell fraction.

Authors:  V Tirino; R Camerlingo; K Bifulco; E Irollo; R Montella; F Paino; G Sessa; M V Carriero; N Normanno; G Rocco; G Pirozzi
Journal:  Cell Death Dis       Date:  2013-05-02       Impact factor: 8.469

5.  The culture of cancer cell lines as tumorspheres does not systematically result in cancer stem cell enrichment.

Authors:  Christophe Y Calvet; Franck M André; Lluis M Mir
Journal:  PLoS One       Date:  2014-02-24       Impact factor: 3.240

6.  RhoC regulates cancer stem cells in head and neck squamous cell carcinoma by overexpressing IL-6 and phosphorylation of STAT3.

Authors:  Mozaffarul Islam; Smita Sharma; Theodoros N Teknos
Journal:  PLoS One       Date:  2014-02-12       Impact factor: 3.240

7.  The synergistic in vitro and in vivo antitumor effect of combination therapy with salinomycin and 5-fluorouracil against hepatocellular carcinoma.

Authors:  Fan Wang; Weiqi Dai; Yugang Wang; Miao Shen; Kan Chen; Ping Cheng; Yan Zhang; Chengfen Wang; Jingjing Li; Yuanyuan Zheng; Jie Lu; Jing Yang; Rong Zhu; Huawei Zhang; Yingqun Zhou; Ling Xu; Chuanyong Guo
Journal:  PLoS One       Date:  2014-05-09       Impact factor: 3.240

Review 8.  Tumorsphere as an effective in vitro platform for screening anti-cancer stem cell drugs.

Authors:  Che-Hsin Lee; Cheng-Chia Yu; Bing-Yen Wang; Wen-Wei Chang
Journal:  Oncotarget       Date:  2016-01-12

9.  What Do We Learn from Spheroid Culture Systems? Insights from Tumorspheres Derived from Primary Colon Cancer Tissue.

Authors:  Komal Qureshi-Baig; Pit Ullmann; Fabien Rodriguez; Sónia Frasquilho; Petr V Nazarov; Serge Haan; Elisabeth Letellier
Journal:  PLoS One       Date:  2016-01-08       Impact factor: 3.240

10.  GP73-regulated oncolytic adenoviruses possess potent killing effect on human liver cancer stem-like cells.

Authors:  Xinmin Zhang; Shulin Meng; Rong Zhang; Buyun Ma; Tao Liu; Yu Yang; Wenjie Xie; Xianglei Liu; Fang Huang; Tao Liu; Xiumei Zhou; Xinyuan Liu; Yigang Wang
Journal:  Oncotarget       Date:  2016-05-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.